SCHEMBL15539229

SCHEMBL15539229

CC(C)(F)CN1CCC(COc2ccc(-c3ccc(C(=O)N4CCCC(O)C4)nc3)cc2F)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
JAK2 O60674 1/20 0.39
SCN9A Q15858 2/20 0.39
ALOX5AP P20292 2/20 0.38
FEN1 P39748 2/20 0.38
DYRK1A Q13627 3/20 0.38
WNT1 P04628 2/20 0.38
MEN1 O00255 1/20 0.38
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
NTRK1 P04629 1/20 0.36
RBP4 P02753 1/20 0.36
MGLL Q99685 1/20 0.36
PRKAB2 O43741 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15539227 1.00 KMT2A (0.41) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL20053618 0.92 DYRK1A (0.41) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL15540083 0.89 JAK2 (0.45) NPC1RAB9AJAK2ALOX5APFEN1
SCHEMBL15539342 0.89 PIK3CA (0.43) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL15538282 0.89 JAK2 (0.45) NPC1RAB9AJAK2ALOX5APFEN1
SCHEMBL15538285 0.89 JAK2 (0.45) NPC1RAB9AJAK2ALOX5APFEN1
SCHEMBL15538965 0.89 PIK3CA (0.43) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL15538969 0.89 PIK3CA (0.43) KMT2ANPC1RAB9AALDH1A1LMNA
SCHEMBL15539689 0.88 KMT2A (0.44) KMT2ANPC1RAB9ASCN9A
SCHEMBL15539687 0.88 KMT2A (0.44) KMT2ANPC1RAB9ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US claimed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP claimed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO claimed
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 KMT2A 1679/4885NPC1 863/4885RAB9A 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.